Published in Blood Weekly, August 9th, 2001
Dr. Stephan Moll, director of the thrombophilia program at the UNC School of Medicine's Center for Thrombosis and Hemostasis, said the studies will help determine the best way to prevent blood clot recurrence. Coumadin, known generically as warfarin, is the standard blood-thinning medication doctors use to treat patients during the first six months after a blood clot is diagnosed, Moll said. However, the drug presents risks, and it topped UNC's recent list of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.